High-sensitivity C-reactive protein
High-sensitivity C-reactive protein (hs-CRP or hsCRP) is a laboratory measure of circulating C-reactive protein (CRP) at concentrations below the range reliably detected by conventional CRP assays.
High-sensitivity C-reactive protein (hs-CRP or hsCRP) is a laboratory measure of circulating C-reactive protein (CRP) at concentrations below the range reliably detected by conventional CRP assays. CRP is an acute-phase protein produced predominantly by the liver in response to inflammatory Signaling, particularly cytokine pathways involving interleukin-6 (IL-6). It participates in innate immune processes, including recognition of tissue injury and altered cellular surfaces. Because hs-CRP can quantify low-grade systemic inflammation, it is used as a clinical metric in cardiovascular risk assessment and in research on obesity, diabetes, kidney disease, atherosclerosis, and other chronic inflammatory conditions.
hs-CRP is a biomarker rather than a disease-specific diagnostic test. Concentrations may increase with infection, tissue injury, obesity, metabolic dysfunction, smoking, and other inflammatory states, so interpretation generally requires clinical context. In cardiovascular medicine, hs-CRP is considered complementary to lipid measurements such as LDL cholesterol: LDL cholesterol reflects an important atherogenic exposure, whereas hs-CRP reflects inflammatory activity associated with cardiovascular disease risk. The POSEIDON study context defined high inflammatory risk as hs-CRP ≥2 mg/L in patients with atherosclerotic cardiovascular disease, with or without chronic kidney disease 42424683Jul. hs-CRP has also been studied in relation to major adverse cardiovascular events, myocardial infarction, stroke, heart failure, cardiovascular Mortality, and All-cause mortality.
Where the papers sit
9 papers from the last 6 months study High-sensitivity C-reactive protein directly · updated from PubMed 7 Nov 2026
Study type 2 clinical trials · 6 observational · 1 human data
Themes one subject
Those 9 are all about one subject.
-
Cardiometabolic Risk and Vascular Outcomes
Risk assessment is shifting toward combining inflammation with adiposity and insulin-resistance measures rather than relying on a single biomarker. hs-CRP recurs alongside lipoprotein(a), interleukin-6, triglyceride-glucose index, visceral adiposity, and estimated glucose disposal rate in studies of metabolic syndrome, diabetes, and atherosclerotic disease. These markers are linked to stroke, acute coronary syndrome, cardiovascular events, and post-stroke outcomes, including across baseline risk strata and albuminuria stages. Tirzepatide analyses extend the work toward testing whether treatment-related biomarker changes track improved cardiometabolic risk.
Papers
The 9 papers from the last 6 months that study High-sensitivity C-reactive protein directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Cardiometabolic Risk and Vascular Outcomes (9)
- Joint associations of estimated glucose disposal rate and high-sensitivity C-reactive protein with metabolic syndrome in Korean adults: A cross-sectional study. Medicine · 6 Nov 2026 PMID 42994858
- Inflammation and lipoprotein(a) as predictors of cardiovascular events across baseline risk levels - results from the UK Biobank. Atherosclerosis · 6 Oct 2026 PMID 42837858
- Growth differentiation factor-15 and body roundness index in relation to cardiometabolic risk in young adults with obesity. Endocrine · 16 Sept 2026 PMID 42747598
- Serum S100B and Its Interplay With hs-CRP and Platelet Count in Association With Adverse Outcomes After Ischemic Stroke. Journal of the American Heart Association · 20 Aug 2026 PMID 42622219
- Triglyceride-glucose index, neutrophil-to-lymphocyte ratio, and high-sensitivity C-reactive protein across albuminuria stages in type 2 diabetes. Scientific reports · 11 Aug 2026 PMID 42581076
- Global prevalence of elevated high-sensitivity C-reactive protein in patients with atherosclerotic cardiovascular disease, with and without chronic kidney disease: findings from the POSEIDON study. Atherosclerosis · 9 Jul 2026 PMID 42424683
- Joint association of high-sensitivity c-reactive protein and Chinese visceral adiposity index with incident stroke in middle-aged and older adults: a prospective cohort study. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association · 24 Jun 2026 PMID 42342095
- Comprehensive Long-Term Changes in Cardiovascular Risk Biomarkers With Tirzepatide: A SURMOUNT-1 Post Hoc Analysis. Journal of the American College of Cardiology · 3 Jun 2026 PMID 42233927
- Interleukin-6 and C-reactive protein prognostic value following acute coronary syndrome. European heart journal · 25 May 2026 PMID 42185072
By study type
Clinical trials (2)
- Comprehensive Long-Term Changes in Cardiovascular Risk Biomarkers With Tirzepatide: A SURMOUNT-1 Post Hoc Analysis. Journal of the American College of Cardiology · 3 Jun 2026 PMID 42233927
- Interleukin-6 and C-reactive protein prognostic value following acute coronary syndrome. European heart journal · 25 May 2026 PMID 42185072
Observational studies and case reports (6)
- Joint associations of estimated glucose disposal rate and high-sensitivity C-reactive protein with metabolic syndrome in Korean adults: A cross-sectional study. Medicine · 6 Nov 2026 PMID 42994858
- Growth differentiation factor-15 and body roundness index in relation to cardiometabolic risk in young adults with obesity. Endocrine · 16 Sept 2026 PMID 42747598
- Serum S100B and Its Interplay With hs-CRP and Platelet Count in Association With Adverse Outcomes After Ischemic Stroke. Journal of the American Heart Association · 20 Aug 2026 PMID 42622219
- Triglyceride-glucose index, neutrophil-to-lymphocyte ratio, and high-sensitivity C-reactive protein across albuminuria stages in type 2 diabetes. Scientific reports · 11 Aug 2026 PMID 42581076
- Global prevalence of elevated high-sensitivity C-reactive protein in patients with atherosclerotic cardiovascular disease, with and without chronic kidney disease: findings from the POSEIDON study. Atherosclerosis · 9 Jul 2026 PMID 42424683
- Joint association of high-sensitivity c-reactive protein and Chinese visceral adiposity index with incident stroke in middle-aged and older adults: a prospective cohort study. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association · 24 Jun 2026 PMID 42342095
Human data, design not indexed (1)
- Inflammation and lipoprotein(a) as predictors of cardiovascular events across baseline risk levels - results from the UK Biobank. Atherosclerosis · 6 Oct 2026 PMID 42837858
Written from 9 PubMed abstracts, each one listed by PMID above. Published: 2026-08-20. Drafted by language models from published abstracts; not medical advice.